Clinical trial
Effect of Pharmacologic Interaction Between Endothelin-Receptor-Antagonists and Phosphodiesterase-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients Wih Pulmonary Arterial Hypertension
NCT02484807 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Pharmacologic Interaction Between Endothelin-Receptor-Antagonists and Phosphodiesterase-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients Wih Pulmonary Arterial Hypertension
- Lead sponsor
- Heidelberg University
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- December 31, 2016
- Enrollment
- 125 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.